Temporal dystrophic remodeling within the intrinsic cardiac nervous system of the streptozotocin-induced diabetic rat model
© Menard et al.; licensee BioMed Central Ltd. 2014
Received: 3 March 2014
Accepted: 19 May 2014
Published: 4 June 2014
The pathogenesis of heart failure (HF) in diabetic individuals, called “diabetic cardiomyopathy”, is only partially understood. Alterations in the cardiac autonomic nervous system due to oxidative stress have been implicated. The intrinsic cardiac nervous system (ICNS) is an important regulatory pathway of cardiac autonomic function, however, little is known about the alterations that occur in the ICNS in diabetes. We sought to characterize morphologic changes and the role of oxidative stress within the ICNS of diabetic hearts. Cultured ICNS neuronal cells from the hearts of 3- and 6-month old type 1 diabetic streptozotocin (STZ)-induced diabetic Sprague-Dawley rats and age-matched controls were examined. Confocal microscopy analysis for protein gene product 9.5 (PGP 9.5) and amino acid adducts of (E)-4-hydroxy-2-nonenal (4-HNE) using immunofluorescence was undertaken. Cell morphology was then analyzed in a blinded fashion for features of neuronal dystrophy and the presence of 4-HNE adducts.
At 3-months, diabetic ICNS neuronal cells exhibited 30% more neurite swellings per area (p = 0.01), and had a higher proportion with dystrophic appearance (88.1% vs. 50.5%; p = <0.0001), as compared to control neurons. At 6-months, diabetic ICNS neurons exhibited more features of dystrophy as compared to controls (74.3% vs. 62.2%; p = 0.0448), with 50% more neurite branching (p = 0.0015) and 50% less neurite outgrowth (p = <0.001). Analysis of 4-HNE adducts in ICNS neurons of 6-month diabetic rats demonstrated twice the amount of reactive oxygen species (ROS) as compared to controls (p = <0.001).
Neuronal dystrophy occurs in the ICNS neurons of STZ-induced diabetic rats, and accumulates temporally within the disease process. In addition, findings implicate an increase in ROS within the neuronal processes of ICNS neurons of diabetic rats suggesting an association between oxidative stress and the development of dystrophy in cardiac autonomic neurons.
The prevalence of diabetes mellitus is increasing at an alarming rate and parallel trends of the incidence of heart failure (HF) [1, 2]. It is estimated that the global number of people living with diabetes will reach 380 million by 2025 [3–6]. While the relationship between heart failure and diabetes can be partially explained by the concomitant risk factors associated with diabetes, evidence now supports diabetes as an independent risk factor for HF [4–9]. HF associated with diabetes mellitus, or “diabetic cardiomyopathy” has been defined to occur in the absence of both obstructive coronary artery disease (CAD) and hypertension [4, 7, 8, 10].
The correlation between diabetic cardiomyopathy (DC) and the development of HF is profound. The Framingham Study found the risk of developing HF to be two times higher in diabetic males, and five times higher in diabetic females, independent of hypertension, age, CAD, obesity and hyperlipidemia [2, 5, 6]. Additionally, diabetes has been used as a prognostic indicator in HF patients [11, 12], with the five-year mortality rate in patients with diabetic autonomic neuropathy having been reported to be as high as 53%, versus 15% with normal autonomic function [13–16]. The underlying pathogenesis of DC is only partially understood, but evidence suggests a link between autonomic dysfunction and abnormal myocardial function (heart rate and myocardial blood flow ) in diabetes mellitus.
Diabetic autonomic neuropathy is a significant clinical complication of diabetes that carries substantial patient mortality and morbidity [13, 14, 17, 18]. The parasympathetic and sympathetic nervous systems have been traditionally thought to operate in a simple relay fashion to control heart rate, but data now demonstrates that the mammalian heart possesses a complex nervous system, the intrinsic cardiac nervous system (ICNS), which can function independently to regulate the heart [19–21]. In vivo analysis of animal and human models have shown that intracardiac neuronal ganglia of the ICNS regulate cardiac output on a real-time, beat-to-beat basis, independent of extracardiac inputs (i.e. from the paravertebral ganglia) [19, 20, 22–24]. As such, the ICNS behaves as a potent neuronal modulator of cardiac function, and has been called the “little brain on the heart”[21, 25]. The ICNS contains afferent neurons [26, 27], sympathetic efferent postganglionic neurons [28–30], parasympathetic efferent postganglionic neurons , and a large population of local circuitry neurons that perform interconnections within the intrinsic cardiac ganglionated plexuses [28, 32]. The characterization of the neurons within the ICNS has been performed on both large [26, 29, 33–35] and small [36–39] animals, as well as the human heart [40–42]. Importantly, the human ICNS behaves in a very similar fashion to that observed in animal models [24, 43]. Given its importance, alteration of ICNS function is thought to play a central role in the pathophysiology of heart failure and arrhythmias [15, 44, 45].
Dystrophic changes in axonal and dendritic morphology, such as neurite swellings, aberrant neurite branching, and decreased neurite outgrowth, in the absence of significant neuronal loss, are the neuropathological hallmarks of diabetic neuropathy [18, 46–48]. The underlying process involved in the development of dystrophic and dysfunctional neurons has yet to be established, however it has been proposed that high serum glucose concentrations results in neurotoxicity with the eventual alteration or loss of nerve fibers [49, 50]. One possible culprit for the proposed neurotoxicity is an increased level of reactive oxygen species (ROS). Cultured adult rat dorsal root ganglion neurons (DRG) exposed to high physiological concentrations of glucose, results in an increased production of ROS, specifically within the neuronal axons, manifesting in axonal swelling and degeneration, but not in cell death . Further evidence for ROS-mediated neurotoxicity was recently described by Campanucci and colleagues, who found that hyperglycemia induced a ROS-mediated depression of acetylcholine-evoked currents in the autonomic neurons of mice, thereby leading to a depression in synaptic transmission .
Previous reports of diabetic neuropathy have largely focused on extracardiac autonomic neurons. Examination of exposure of the isolated ICNS neurons to high glucose concentration has not been previously examined. We therefore sought to characterize the morphology of cultured ICNS in a diabetic rodent model. Secondly, we sought to examine the role of oxidative stress in the pathogenesis of neuronal dystrophy in the ICNS of a diabetic heart.
Materials and methods
Statement of ethics
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). All animal experiment protocols were approved by the University of Manitoba Animal Care Committee following the guidelines established by the Canadian Council on Animal Care.
Primary cell culture
Characteristics of animal cohorts
Body weight (g)
Blood glucose (mmol/l)
613.4 ± 58.5
8.3 ± 0.8
Diabetic (3 mth)
382.2 ± 49.6*
34.0 ± 3.3*
760.7 ± 61.8
8.1 ± 0.8
3.6 ± 0.2
Diabetic (6 mth)
421.6 ± 52.5*
30.9 ± 3.3*
10.0 ± 2.1*
Preparation of cover slips
One day prior to cell isolation, sterile 22 mm coverslips (VWR, Mississauga, ON) were placed in 6-well culture plates and washed 3X with 2 ml of 1xPBS. The coverslips were coated in 1.5 ml of 0.5 mg/ml poly-DL-polyornithine (PORN) (Sigma-Aldrich, St. Louise, MO) and placed in a 37°C incubator overnight. On the morning of the isolation, the PORN was removed and the coverslips were washed with Ham’s F-12 nutrient mixture medium (F12 - Invitrogen, Carlsbad, CA). The coverslips were then coated with 1.5 ml of 1 μg/ml laminin (Nunclon Surface, Ottawa, ON, Canada) in F12 medium for 3 hours at a 37°C. The laminin was then removed and the cover slips washed 3X with F12 medium just prior to the addition of the cells.
Preparation of growth medium
The growth medium used for neuronal culture consisted of Ham’s F12 medium, plus several additives. The neurotrophic factors were 0.3ng/ml of nerve growth factor beta (NGF-ß - Sigma-Aldrich, St. Louise, MO), 1 ng/ml of neurotrophin-3 (NT-3 - Sigma-Aldrich, St. Louise, MO), and 5 ng/ml of glial cell line-derived neurotrophic factor (GDNF - Sigma-Aldrich, St. Louise, MO). The stock N2 additive was prepared in F12 medium without antibiotic or insulin, and was composed of progesterone (Sigma-Aldrich, St. Louise, MO), putrescine (Sigma-Aldrich, St. Louise, MO), sodium selenite (Sigma-Aldrich, St. Louise, MO), fatty-acid free BSA powder (Sigma-Aldrich, St. Louise, MO), and transferrin (Sigma-Aldrich, St. Louise, MO). 40 μl of stock N2 was added per 4 ml of growth medium, bringing the final concentrations to 20 nM of progesterone, 100 μM of putrescine, 30 nM of sodium selinite, 0.1 mg/ml of BSA and 100 μg/ml of transferrin. To this standard growth medium (containing 10mM glucose), 0.1 nM of insulin was added, while a final concentration of 25 mM of glucose and zero insulin was used in the diabetic growth medium. It has been demonstrated that adult neurons do not undergo apoptosis under this high glucose preparation .
After 72 hours in culture, the neurons were fixed with 4% paraformaldehyde in phosphate buffer at pH 7.4 for 15 min, followed by permeation with 0.3% Triton X-100 in PBS. Nonspecific binding was blocked by incubation with Blocking Reagent (Roche, Indianapolis, IN) combined with FBS and 1.0 M PBS in proportions of 3:1:1 for 1 hr at room temperature, followed by three washes with PBS. The coverslips were incubated in polyclonal antibody to amino acid adducts of (E)-4-hydroxy-2-nonenal (1:500 anti-4-HNE adducts Pab; Alexis Biochemicals, San Diego, CA) overnight at 4ºC in a humidified chamber. The next day, coverslips were washed several times in 1XPBS, followed by incubation in Alexa Flour 488 (Molecular Probes, Burlington, ON; 1:700) secondary antibody for 3 hr at room temperature. The coverslips were washed again in 1XPBS, and incubated with polyclonal anti-protein gene product (PGP) 9.5 (1:500 – UltraClone Limited, Isle of Wight, England) overnight at 4°C in a humidified chamber in the dark. The coverslips were then washed in 1XPBS, and then incubated for three hours with Alexa Fluor 546 (1:700). Coverslips were mounted to microscope slides using mounting medium with DAPI, Hard Set (Vector, Cat#H-1500). A Carl Zeiss LSM510 inverted confocal microscope was utilized for identification of neurons throughout specimens. Confocal images were captured using a Plan-Neofluar 40x/1.3 Oil DIC objective at 10 μm intervals ascending from the substrate though neuronal cell bodies and processes (Z sections). The images were reconstructed in three dimensions using Zeiss LSM Image Browser software (Germany).
4-HNE adduct analysis
The confocal images captured were analyzed with ImageJ 1.42 software in a blinded fashion. Fluorescence images of 4-HNE adduct staining immunoreactive neurons were separated from their surroundings by a threshold value, the cell body was deleted from the image, and measurements were made to score both the immunoreactive area within the pixel range and the intensity of the fluorescence. The average intensity of fluorescence was then divided by the average area of fluorescence.
All data, with the exception of the dystrophic neuronal proportions, was subject to standard two-tailed unpaired Student’s t-Test with significance levels of p = 0.05, which does not assume equal variances, using GraphPad Prism 4 (GraphPad Prism 4, GraphPad Software Inc., San Diego, CA) . All results are expressed as mean ± SEM. The data for the proportion of dystrophic neurons was compared using a normal approximation method (need references).
Morphology of primary ICNS cultures
Effect of diabetes on neurite outgrowth
Expression of 4-HNE adducts
This study demonstrated that isolated intrinsic cardiac neurons from adult STZ-diabetic and age-matched control rats can be maintained in culture, and that ICNS neurons show varied morphology, indicative of the cell types that exist in vivo within the cardiac ganglia. It was further demonstrated that neuronal dystrophy occurs in the ICNS neurons of STZ-induced diabetic rats, and accumulates temporally within the disease process. In addition, an increase in 4-HNE adducts occurs in the neuronal processes implicating an association between oxidative stress and the development of a dystrophy in cardiac autonomic neurons. At the time of writing this manuscript, we are not aware of any previous study examining the effect of high-glucose on the cardiac autonomic nervous system.
Analysis of the 3-month data indicated that only one quantifiable dystrophic feature, the number of neurite swellings, was significantly greater in the diabetic ICNS neurons. Neurite swellings, thought to be the residues of aberrant intra-ganglionic sprouting, may be axonal or dendritic in nature, and have been described as being large accumulations of small mitochondria and neuronal structural proteins [18, 46, 47, 51]. The significance of neurite swellings in the pathogenesis of neuronal dysfunction may be two-fold. Firstly, the collection of debris may reflect or induce alterations in axonal transport [55, 58]. Altered axonal transport may result in death of mitochondria and the absence of structural proteins at distal sites, and the distal axon, lacking the sufficient tools for plasticity, is predisposed to dissolution upon subsequent injury or stress [18, 51]. Secondly, the collection of mitochondria themselves may produce a local exaggeration of oxidative stress via the overproduction of superoxide by the electron transport chain in the mitochondria, leading to a self-propagating pathway of neuritic dystrophy [18, 59]. In accordance with this view, the neurite swellings exhibited a greater level of 4-HNE adduct expression (Figure 6).
At 6-months, an increase in the number of dystrophic features was observed in the diabetic ICNS neurons, with two quantifiable dystrophic features (area of neuronal outgrowth and neurite branching) being significantly different from controls. Increased neurite branching has been postulated as a compensatory response of a neuron to a loss of synapses occurring along their length [60, 61]. An aberrant increase in branching morphology has also been observed in neurons affected with Alzheimer’s disease (AD), characterized by a pattern of ineffective intensive growth . Given the parallels that have been drawn between the effects of AD and diabetes on neurons, it is possible that this type of neurite branching may also be occurring in diabetic neurons [62–64]. Furthermore, increased neurite branching has been described in diabetic rat neurons of prevertebral and paravertebral sympathetic ganglia . In diabetic neurons, the development of axonal sprouts appears to serve as a substrate for further dystrophic changes, with their appearance preceding the development of axonal swellings [48, 65]. At 6 months, the decrease in area of neuronal outgrowth as compared to controls is an expected and often observed finding in dystrophic diabetic neurons, owing to the degeneration of axons and nerve fiber loss [46, 58, 66]. The number of neurite swellings did not differ significantly between the 6-month diabetic and control neuronal groups.
Overall, analysis of 3-month and 6-month data demonstrated an increase in the dystrophic features in the diabetic neurons between the two time points, with two of the dystrophic features being more prominent in the 6-month diabetics, compared to only one feature for the 3-month diabetics. Importantly, it has been demonstrated in other diabetic rat peripheral neurons that the dystrophic effects of diabetes accumulate temporally, with dysmorphology progressing from mild at early time points to more pronounced at later time points . Given the temporal relationship between our two experimental groups, our data is in agreement with these findings.
Due to the observed tortuosity in the neuronal processes, we performed a confirmatory analysis of dystrophic phenotype for the ICNS neurons. The classification of neurons into dystrophic or non-dystrophic categories was undertaken so as to compare neurons as a whole . Importantly, at both time points, there was a significantly higher proportion of any dystrophy (mild or high) in the diabetic neurons. That the 6-month diabetic group did not exhibit a significantly greater proportion of highly dystrophic neurons was not an expected result, but a possible explanation is that age itself produces similar dystrophic changes in neuronal morphology .
Several studies have confirmed staining for the presence of 4-HNE adducts as a marker for oxidative stress [51, 52, 55, 68, 69]. 4-HNE adducts are produced via oxidative stress dependent-lipid peroxidation , and it has been proposed that oxidative stress plays an important role in the formation of diabetes-associated dystrophic neuronal features [55, 68]. Given the significant increase in the intensity of staining for 4-HNE adducts in the 6-month diabetic neurons, our study provides evidence to support this hypothesis. As the 3-month diabetic neurons did not show a difference in staining intensity compared to the control group, this speaks to the aforementioned increase in dystrophy that is seen to occur temporally in diabetes . As stated previously, another important finding in our study was the increased intensity of staining for 4-HNE adducts that was observed inside the neurite swellings (Figure 6), which supports the notion that oxidative stress is associated with the formation of dystrophic features in diabetic neurons [55, 59].
This data adds to the growing body of evidence supporting the physiologic importance of ICNS in the diabetic heart. A recent study by Mabe and Hoover  illustrated that a functional parasympathetic nervous system cannot negate the deleterious effects of a dysfunctional ICNS. Using a STZ-mouse model, they demonstrated a reduction in resting heart rate, as well as alterations with high and low frequency power (via spectral analysis of electrocardiograms), in diabetic mice, suggesting a relative reduction of parasympathetic tone. Further confirmation via immunohistochemical analysis demonstrated no loss of cardiac cholinergic neurons or nerve fibers, nor altered cholinergic sensitivity of the atria. The authors thus concluded that the observed heart rate abnormalities in the diabetic mice may be as a result of defective ganglionic neurotransmission. The dysmorphic alterations observed in our analysis of diabetic ICNS neurons supports their proposition that the true neuronal dysfunction lies within the intracardiac ganglia.
We acknowledge that a limitation of our analysis is the lack of in vivo functional correlation to the morphologic changes observed in the in vitro data presented. This may have best been achieved with the use of some in vivo assessment, such as echocardiography or other real-time imaging modality. While we unfortunately did not have access to this technology at the time of the study, other investigators have demonstrated a correlation with STZ-induced DM in rodents and left ventricular systolic and diastolic dysfunction, fibrosis and abnormal SERCA2a activity [71, 72]. In addition, previous work examining the alterations of the intrinsic cardiac nervous system in disease states, in both animal [73–76] and human models , have demonstrated functional remodeling of ICNS neurotransmission to have profound effects on cardiodynamics.
A second limitation of our study is the inability to draw causality between the increase in 4-HNE staining and ROS-induced toxicity. To further elucidate the role of ROS in neuronal dysmorphology and dysfunction, experimentation with anti-oxidants, as well as electrophysiology studies should be undertaken. Additional work will also be necessary to further characterize the observed neurite swellings as axonal or dendritic, and to confirm the contents of the neurite swellings. Furthermore, our study did not address the role of this ROS-induced toxicity on neuronal cell viability. Future studies investigating cell viability and apoptosis would be helpful to determine whether neuronal dysfunction is also the result of neuronal cell loss in the intracardiac ganglia.
Our study demonstrated for the first time in ICNS neurons of STZ-diabetic rats that dystrophic features accumulate temporally in diabetic neurons, and that features associated with neuronal oxidative stress are observed concurrently with the development of dystrophy. This study also challenged the notion that the measurement of total area of neuronal outgrowth is a sufficient measure of neuronal outgrowth. Given the observed tortuosity of neuronal processes, additional methods for neurite outgrowth assessments, such as the length of the longest axon, might be more informative. While this data provides the inference of ROS as a mechanism of morphologic changes that occur in the ICNS when exposed to high-glucose concentrations, research is required to confirm that oxidative stress plays a causative role in dystrophic changes, and to evaluate whether the dystrophic changes observed in diabetic rat ICNS neurons leads to neuronal dysfunction.
Availability of supporting data
The data set(s) supporting the results of this article is (are) included within the article (and its additional file(s).
Intrinsic cardiac nervous system
Coronary artery disease
Reactive Oxygen Species
Dorsal Root Ganglion
Fetal bovine serum
Polyclonal anti-protein gene product
Funding was from CIHR to Dr. Fernyhough (MOP-84214)
University of Manitoba, Department of Surgery, Manitoba Health Research Council, Manitoba Medical Service Foundation.
- Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993, 88: 107–115.View ArticlePubMedGoogle Scholar
- Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22: 6A-13A.View ArticlePubMedGoogle Scholar
- King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21: 1414–1431.View ArticlePubMedGoogle Scholar
- Khavandi K, Khvandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA: Diabetic cardiomyopathy–a distinct disease? Best Pract Res Clin Endocrinol Metab 2009, 23: 347–360.View ArticlePubMedGoogle Scholar
- Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241: 2035–2038.View ArticlePubMedGoogle Scholar
- Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2: 120–126.View ArticlePubMedGoogle Scholar
- Iltis I, Kober F, Dalmasso C, Cozzone PJ, Bernard M: Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling MRI. Microcirculation 2005, 12: 607–614.View ArticlePubMedGoogle Scholar
- Hayat SA, Patel B, Khattar RS, Malik RA: Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004, 107: 539–557.View ArticleGoogle Scholar
- Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB: The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001, 37: 1943–1949.View ArticlePubMedGoogle Scholar
- Scognamiglio R, Casara D, Avogaro A: Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998, 31: 404–412.View ArticlePubMedGoogle Scholar
- Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC: Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996, 77: 1017–1020.View ArticlePubMedGoogle Scholar
- Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J: Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 2008, 94: 296–304.View ArticlePubMedGoogle Scholar
- Gerritsen J, Dekker JM, TenVoorde BJ, Krostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001, 24: 1793–1798.View ArticlePubMedGoogle Scholar
- Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Doring A, Meisinger C: Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008, 31: 556–561.View ArticlePubMedGoogle Scholar
- Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003, 26: 1553–1579.View ArticlePubMedGoogle Scholar
- Cheng YJ, Lauer MS, Earnest CP, Church TS, Kampert JB, Gibbons LW, Blair SN: Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care 2003, 26: 2052–2057.View ArticlePubMedGoogle Scholar
- Rundles RW: Diabetic neuropathy. Bull N Y Acad Med 1950, 26: 598–616.PubMedPubMed CentralGoogle Scholar
- Schmidt RE, Dorsey DA, Beaudet LN, Frederick KE, Parvin CA, Plurad SB, Levisetti MG: Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am J Pathol 2003, 163: 2077–2091.View ArticlePubMedPubMed CentralGoogle Scholar
- Ardell JL, Butler CK, Smith FM, Hopkins DA, Armour JA: Activity of in vivo atrial and ventricular neurons in chronically decentralized canine hearts. Am J Physiol 1991, 260: H713-H721.PubMedGoogle Scholar
- Arora RC, Ardell JL, Armour JA: Cardiac Denervation and Cardiac Function. Curr Interv Cardiol Rep 2000, 2: 188–195.PubMedGoogle Scholar
- Armour JA: Potential clinical relevance of the 'little brain' on the mammalian heart. Exp Physiol 2008, 93: 165–176.View ArticlePubMedGoogle Scholar
- Armour JA: Cardiac neuronal hierarchy in health and disease. Am J Physiol Regul Integr Comp Physiol 2004, 287: R262-R271.View ArticlePubMedGoogle Scholar
- Horackova M, Armour JA: Role of peripheral autonomic neurones in maintaining adequate cardiac function. Cardiovasc Res 1995, 30: 326–335.View ArticlePubMedGoogle Scholar
- Arora RC, Hirsch GM, Johnson-Hirsch K, Hancock-Friesen C, Armour JA: Function of human intrinsic cardiac neurons in situ. Am J Physiol Regul Integr Comp Physiol 2001, 280: R1736-R1740.PubMedGoogle Scholar
- Armour JA: Myocardial ischaemia and the cardiac nervous system. Cardiovasc Res 1999, 41: 41–54.View ArticlePubMedGoogle Scholar
- Armour JA, Hopkins DA: Activity of in vivo canine ventricular neurons. Am J Physiol 1990, 258: H326-H336.PubMedGoogle Scholar
- Cheng Z, Powley TL, Schwaber JS, Doyle FJ: Vagal afferent innervation of the atria of the rat heart reconstructed with confocal microscopy. J Comp Neurol 1997, 381: 1–17.View ArticlePubMedGoogle Scholar
- Butler CK, Smith FM, Cardinal R, Murphy DA, Hopkins DA, Armour JA: Cardiac responses to electrical stimulation of discrete loci in canine atrial and ventricular ganglionated plexi. Am J Physiol 1990, 259: H1365-H1373.PubMedGoogle Scholar
- Gagliardi M, Randall WC, Bieger D, Wurster RD, Hopkins DA, Armour JA: Activity of in vivo canine cardiac plexus neurons. Am J Physiol 1998, 255: H789-H800.Google Scholar
- Hamos JE, Van Horn SC, Raczkowski D, Uhlrich DJ, Sherman SM: Synaptic connectivity of a local circuit neurone in lateral geniculate nucleus of the cat. Nature 1985, 317: 618–621.View ArticlePubMedGoogle Scholar
- Blomquist TM, Priola DV, Romero AM: Source of intrinsic innervation of canine ventricles: a functional study. Am J Physiol 1987, 252: H638-H644.PubMedGoogle Scholar
- Murphy DA, O'Blenes S, Hanna BD, Armour JA: Functional capacity of nicotine-sensitive canine intrinsic cardiac neurons to modify the heart. Am J Physiol 1994, 266: R1127-R1135.PubMedGoogle Scholar
- Arora RC, Waldmann M, Hopkins DA, Armour JA: Porcine intrinsic cardiac ganglia. Anat Rec A: Discov Mol Cell Evol Biol 2003, 271: 249–258.View ArticleGoogle Scholar
- Hopkins DA, Gootman PM, Gootman N, Armour JA: Anatomy of medullary and peripheral autonomic neurons innervating the neonatal porcine heart. J Auton Nerv Syst 1997, 64: 74–84.View ArticlePubMedGoogle Scholar
- Pauza DH, Skripka V, Pauziene N: Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing histochemical staining with acetylcholinesterase. Cells Tissues Organs 2002, 172: 297–320.View ArticlePubMedGoogle Scholar
- Pauza DH, Skripkiene G, Skripka V, Pauziene N, Stropus R: Morphological study of neurons in the nerve plexus on heart base of rats and guinea pigs. J Auton Nerv Syst 1997, 62: 1–12.View ArticlePubMedGoogle Scholar
- Pauziene N, Pauza DH, Stropus R: Morphological study of the heart innervation of bats Myotis daubentoni and Eptesicus serotinus (Microchiroptera: Vespertilionidae) during hibernation. Eur J Morphol 2000, 38: 195–205.View ArticlePubMedGoogle Scholar
- Richardson RJ, Grkovic I, Anderson CR: Immunohistochemical analysis of intracardiac ganglia of the rat heart. Cell Tissue Res 2003, 314: 337–350.View ArticlePubMedGoogle Scholar
- Roberts LA: Morphological innervation pattern of the developing rabbit heart. Am J Anat 1991, 190: 370–384.View ArticlePubMedGoogle Scholar
- Pauza DH, Skripka V, Pauziene N, Stropus R: Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000, 259: 353–382.View ArticlePubMedGoogle Scholar
- Pauziene N, Pauza DH, Stropus R: Morphology of human intracardiac nerves: an electron microscope study. J Anat 2000, 197: 437–459.View ArticlePubMedPubMed CentralGoogle Scholar
- Hoover DB, Isaacs ER, Jacques F, Hoard JL, Page P, Armour JA: Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience 2009, 164: 1170–1179.View ArticlePubMedGoogle Scholar
- Murphy DA, Armour JA: Human cardiac nerve stimulation. Ann Thorac Surg 1992, 54: 502–506.View ArticlePubMedGoogle Scholar
- Maser RE, Lenhard MJ: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab 2005, 90: 5896–5903.View ArticlePubMedGoogle Scholar
- Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007, 115: 387–397.View ArticlePubMedGoogle Scholar
- Schmidt RE: Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol 2002, 50: 257–292.View ArticlePubMedGoogle Scholar
- Schmidt RE, Parvin CA, Green KG: Synaptic ultrastructural alterations anticipate the development of neuroaxonal dystrophy in sympathetic ganglia of aged and diabetic mice. J Neuropathol Exp Neurol 2008, 67: 1166–1186.View ArticlePubMedPubMed CentralGoogle Scholar
- Schmidt RE, Dorsey DA, Roth KA, Parvin CA, Hounsom L, Tomlinson DR: Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res 2000, 867: 149–156.View ArticlePubMedGoogle Scholar
- Russell JW, Golovoy D, Vincent AM, Mahendry P, Otzmann JA, Mentzer A, Feldman EL: High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002, 16: 1738–1748.View ArticlePubMedGoogle Scholar
- Vincent AM, Brownlee M, Russell JW: Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci 2002, 959: 368–383.View ArticlePubMedGoogle Scholar
- Zherebitskaya E, Akude E, Smith DR, Fernyhough P: Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 2009, 58: 1356–1364.View ArticlePubMedPubMed CentralGoogle Scholar
- Campanucci V, Krishnaswamy A, Cooper E: Diabetes depresses synaptic transmission in sympathetic ganglia by inactivating nAChRs through a conserved intracellular cysteine residue. Neuron 2010, 66: 827–834.View ArticlePubMedGoogle Scholar
- Horackova M, Slavikova J, Byczko Z: Postnatal development of the rat intrinsic cardiac nervous system: a confocal laser scanning microscopy study in whole-mount atria. Tissue Cell 2000, 32: 377–388.View ArticlePubMedGoogle Scholar
- Horackova M, Croll RP, Hopkins DA, Losier AM, Armour JA: Morphological and immunohistochemical properties of primary long-term cultures of adult guinea-pig ventricular cardiomyocytes with peripheral cardiac neurons. Tissue Cell 1996, 28: 411–425.View ArticlePubMedGoogle Scholar
- Valencia A, Sapp E, Kimm JS, McClory H, Alexander J, Ansong KA, Frosch MP, Kegel KB, Li X, DiFiglia M: Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. Hum Mol Genet 2013, 22: 1112–1131.View ArticlePubMedGoogle Scholar
- Grace EA, Rabiner CA, Busciglio J: Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 2002, 114: 265–273.View ArticlePubMedGoogle Scholar
- Hoard JL, Hoover DB, Wondergem R: Phenotypic properties of adult mouse intrinsic cardiac neurons maintained in culture. Am J Physiol Cell Physiol 2007, 293: C1875-C1883.View ArticlePubMedGoogle Scholar
- Roediger B, Armati PJ: Oxidative stress induces axonal beading in cultured human brain tissue. Neurobiol Dis 2003, 13: 222–229.View ArticlePubMedGoogle Scholar
- Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414: 813–820.View ArticlePubMedGoogle Scholar
- Dickstein DL, Brautigam H, Stockton SD Jr, Schmeidler J, Hof PR: Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau. Brain Struct Funct 2010, 214: 161–179.View ArticlePubMedPubMed CentralGoogle Scholar
- Arendt T, Bruckner MK, Bigl V, Marcova L: Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J Comp Neurol 1995, 351: 189–222.View ArticlePubMedGoogle Scholar
- de la Monte SM, Wands JR: Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008, 2: 1101–1113.View ArticlePubMedPubMed CentralGoogle Scholar
- de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR: Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 2006, 10: 89–109.PubMedGoogle Scholar
- Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E: Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 2008, 86: 3265–3274.View ArticlePubMedPubMed CentralGoogle Scholar
- Schmidt RE: Synaptic dysplasia in sympathetic autonomic ganglia. J Neurocytol 1996, 25: 777–791.View ArticlePubMedGoogle Scholar
- Kamiya H, Zhang W, Sima AA: Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes. Exp Diabetes Res 2009, 2009: 793281.View ArticlePubMedPubMed CentralGoogle Scholar
- Schmidt RE, Plurad SB, Parvin CA, Roth KA: Effect of diabetes and aging on human sympathetic autonomic ganglia. Am J Pathol 1993, 143: 143–153.PubMedPubMed CentralGoogle Scholar
- Akude E, Zherebitskaya E, Roy-Chowdhury SK, Girling K, Fernyhough P: 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res 2010, 17: 28–38.View ArticlePubMedGoogle Scholar
- Bodiga VL, Eda SR, Bodiga S: Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev 2013, 19: 49–63.View ArticleGoogle Scholar
- Mabe AM, Hoover DB: Remodeling of cardiac cholinergic innervation and control of heart rat in mice with streptozotocin-induced diabetes. Auton Neurosci 2011, 162: 24–31.View ArticlePubMedGoogle Scholar
- Hou J, Zheng J, Zhong G, Hu Y: Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats. Can J Physiol Pharmacol 2013, 91: 759–763.View ArticlePubMedGoogle Scholar
- Epp RA, Susser SE, Morissette MP, Kehler DS, Jassal DS, Duhamel TA: Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet. Can J Physiol Pharamacol 2013, 91: 80–89.View ArticleGoogle Scholar
- Armour JA, Linderoth B, Arora RC, DeJongste MJL, Ardell JL, Kindma JG, Jill M, Foreman RD: Long-term modulation of the intrinsic cardiac nervous system by spinal cord neurons in normal and ischaemic hearts. Auton Neuroci 2002, 95: 71–79.View ArticleGoogle Scholar
- Arora RC, Hirsch GM, Hirsch K, Armour JA: Transyocardial laser revascularlization remodels the intrinsic cardiac nervous system in a chronic setting. Circulation 2001, 104: 115–120.View ArticleGoogle Scholar
- Arora RC, Cardinal R, Smith RM, Ardell JL, Dell'Italia LJ, Armour JA: Intrinsic cardiac nervous system in tachycardia induced heart failure. Am J Physiol Regul Integr Comp Physiol 2003, 285: R121201213.View ArticleGoogle Scholar
- Galoyan A, Srapionian R, Arora RC, Armour JA: Responsiveness of intrinsic cardiac neurons to the left atrial and hypothalamic cardioactive peptides. Auton Neurosci 2001, 92: 11–20.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.